CTRI/2023/02/049958招募中未知
A PLACEBO CONTROLLED DOUBLE BLIND RANDOMIZED CONTROL STUDY TO EVALUATE THE EFFECT OF VITAMIN E AND SAROGLITAZAR IN LEAN NASH
试验速览
- 阶段
- 未知
- 状态
- 招募中
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Age > 18 Years
- •BMI <23 kg/m2
- •Patient with fatty liver disease, chronic liver disease without ascites (Child Pugh score <8)
排除标准
- •Decompensated cirrhosis
- •Allergy to Vitamin E or SAROGLITAZAR
- •BMI > 23 kg/m2
研究者
相似试验
招募中
2 期
To see effetiveness of homoeopathic medicines on chronic rhinosinusitis against placeboCTRI/2012/01/002320Central Council for Research in Homoeopathy120
已完成
2 期
Ayurvedic treatment for mild and moderate depressioCTRI/2019/08/020868SDM Pharmacy Udupi160
进行中（未招募）
不适用
A RANDOMIZED, DOUBLE BLIND, PLACEBO CONTROLLED DETROL LA ADD-ON TO ALPHA-BLOCKER STUDY IN MEN WITH PERSISTENT OVERACTIVE BLADDER SYMPTOMS OF URINARY FREQUENCY AND URGENCY WITH/WITHOUT URGENCY INCONTINENCE AFTER PREVIOUS MONOTHERAPY WITH ALPHA BLOCKER - NDOveractive Bladder in MenMedDRA version: 6.1Level: PTClassification code 10046494EUCTR2005-004452-13-ITPFIZER608
进行中（未招募）
1 期
A Placebo-Controlled, Randomized Double-Blind Parallel Group 12-Month Trial of Fasudil for the Treatment of Early Alzheimer’s DiseaseMedDRA version: 21.1Level: LLTClassification code: 10009846Term: Cognitive impairment Class: 10029205MedDRA version: 20.0Level: LLTClassification code: 10001896Term: Alzheimer's disease Class: 10029205Alzheimer's diseaseCTIS2023-506514-44-00Helse Stavanger HF200
已完成
不适用
A RANDOMIZED, DOUBLE BLIND, PLACEBO CONTROLLED, CROSS-OVER, ASCENDING SINGLE ORAL DOSE, SAFETY, TOLERABILITY AND PHARMACOKINETIC STUDY OF CB-189,625 IN HEALTHY MALE SUBJECTS.acute en chronische pijnacute and chronic painNL-OMON37794Cubist Pharmaceuticals, Inc18